UK government urged to create parallel domestic supply chain for key medicines

29 July 2020
money_drugs_uk-1-

A parliamentary committee has advised the government to create a parallel domestic supply chain for certain medicines to ensure the UK can cope with future health crises.

The International Trade Committee (ITC) has published its report, The Covid-19 Pandemic and International Trade, covering factors including the major disruption caused to pharmaceutical supply chains around China and India, which left the UK at serious risk of shortages of key drugs including paracetamol.

Failures highlighted within global supply chain

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical